Projects per year
Personal profile
Research Area Keywords
- Neurosciences
- Clinical Translation & Trials
Fingerprint
Dive into the research topics where Sheetal Shroff is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects with Non-Oncology Plasma Cell-Related Diseases
Liao, B. (PI), Ganguly, S. (Key Personnel), Greene, E. P. (Key Personnel) & Shroff, S. (Key Personnel)
5/12/25 → …
Project: Clinical Trial
-
An open-label, multi-center, phase I/II study to assess safety, efficacy, and cellular kinetics of YTB323 in participants with treatment-resistant generalized myasthenia gravis.
Greene, E. P. (PI), Liao, B. (Key Personnel) & Shroff, S. (Key Personnel)
5/8/25 → …
Project: Clinical Trial
-
An open-label single center, single participant study of an experimental antisense oligonucleotide treatment for amyotrophic lateral sclerosis (ALS) due to TARDBP (TDP-43) genetic mutation
Shroff, S. (PI) & Appel, S. H. (Key Personnel)
3/26/25 → …
Project: Clinical Trial
-
A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants with Amyotrophic Lateral Sclerosis
Shroff, S. (PI)
2/16/24 → 12/31/25
Project: Non Profit
-
MGH Healey Platform Trial Regimen-Specific Appendix F - ABBV-CLS-7262
Shroff, S. (PI)
5/31/23 → 7/23/25
Project: Non Profit
-
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
MG0003 study team, May 2023, In: The Lancet Neurology. 22, 5, p. 383-394 12 p.Research output: Contribution to journal › Article › peer-review
139 Scopus citations -
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development
for the Healey ALS Platform Trial Study Group, HEALEY ALS Platform Trial Study Group, Biostatisticians, Investigators, Clinical Operations Team & Medical Monitors, Feb 1 2022, In: Annals of Neurology. 91, 2, p. 165-175 11 p.Research output: Contribution to journal › Article › peer-review
64 Scopus citations -
It's Not All in Your Head: Thoracic Manifestations of Neurologic Diseases and Disorders
Shroff, G. S., Wu, C. C., Ocazionez, D., Carter, B. W., Shivaprasad, A., Chai, T., Supsupin, E. P., Truong, M. T. & Shroff, S., May 2022, In: Academic Radiology. 29, 5, p. 736-747 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Imaging spectrum of adverse events of immune checkpoint inhibitors
Shroff, G. S., Shroff, S., Ahuja, J., Truong, M. T. & Vlahos, I., Apr 2021, In: Clinical Radiology. 76, 4, p. 262-272 11 p.Research output: Contribution to journal › Review article › peer-review
9 Scopus citations -
Immune-Mediated Neuropathies
Fadia, M., Shroff, S. & Simpson, E., Jun 1 2019, In: Current Treatment Options in Neurology. 21, 6, 28.Research output: Contribution to journal › Review article › peer-review
12 Scopus citations